Financhill
Back

Trex Vs. Ultragenyx Pharmaceutical Industry Stock Comparison

Sell
44

TREX
Trex

Last Price:
83.72
Seasonality Move:
4.47%
Sell
41

RARE
Ultragenyx Pharmaceutical

Last Price:
39.79
Seasonality Move:
3.65%
Sell
44
Trex (TREX) is a Sell

Is Trex a Buy, Sell or Hold?

  • The current Trex [TREX] share price is $83.71. The Score for TREX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
  • TREX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
41
Ultragenyx Pharmaceutical (RARE) is a Sell

Is Ultragenyx Pharmaceutical a Buy, Sell or Hold?

  • The current Ultragenyx Pharmaceutical [RARE] share price is $39.80. The Score for RARE is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TREX Stock Price Chart

What is Trex's stock price today?

  • The Trex share price today is $83.71
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TREX is experiencing slight buying pressure.

RARE Stock Price Chart

What is Ultragenyx Pharmaceutical's stock price today?

  • The Ultragenyx Pharmaceutical share price today is $39.80
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RARE is experiencing buying pressure, which is a positive indicator for future bullish movement.

TREX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.45 Sell
Relative Strength Index (14 RSI): 44.15 Sell
Chaikin Money Flow: 234215 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.93 - 88.49) Sell
Bollinger Bands (100): (85.4 - 95.32) Sell

RARE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.3 Sell
Relative Strength Index (14 RSI): 44 Sell
Chaikin Money Flow: 896649 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (39.57 - 42.35) Sell
Bollinger Bands (100): (41.42 - 48.86) Sell

TREX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 83.15 Buy
20-day SMA: 84.92 Sell
50-day SMA: 88.2 Sell
200-day SMA: 79.45 Buy
8-day EMA: 84.01 Sell
20-day EMA: 85.02 Sell
50-day EMA: 87.36 Sell
200-day EMA: 81.33 Buy

RARE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 41.65 Sell
20-day SMA: 40.82 Sell
50-day SMA: 42.69 Sell
200-day SMA: 42.45 Sell
8-day EMA: 41.15 Sell
20-day EMA: 41.29 Sell
50-day EMA: 42.49 Sell
200-day EMA: 43.61 Sell

Trex Earnings Growth & TREX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.38 per share, an increase this year of $0.40 per share, and an increase next year of $0.28 per share.

Ultragenyx Pharmaceutical Earnings Growth & RARE Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.47 per share, an increase next quarter of $0.03 per share, an increase this year of $0.84 per share, and an increase next year of $1.07 per share.

Trex Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ultragenyx Pharmaceutical Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):